Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

Huntington Disease (HD) is characterized by choreic involuntary movements and striatal vulnerability. A2A receptors expressed on GABAergic striatal neurons have been suggested to play a pathogenetic role. Previous data demonstrated the presence of an aberrant alteration of A2A receptor-dependent ade...

Full description

Bibliographic Details
Main Authors:	Alessia Tarditi, Alessandra Camurri, Katia Varani, Pier Andrea Borea, Ben Woodman, Gillian Bates, Elena Cattaneo, Maria P. Abbracchio
Format:	Article
Language:	English
Published:	Elsevier 2006-07-01
Series:	Neurobiology of Disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996106000180

Similar Items

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain
by: Fabrizio Vincenzi, et al.
Published: (2020-11-01)

Adenosine and Inflammation: Here, There and Everywhere
by: Silvia Pasquini, et al.
Published: (2021-07-01)

A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
by: Fabrizio Vincenzi, et al.
Published: (2020-12-01)

Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease
by: Antonella Ferrante, et al.
Published: (2014-11-01)

Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages
by: K. Varani, et al.
Published: (2007-07-01)

An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
by: Stefania Merighi, et al.
Published: (2021-03-01)

A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
by: Stefania Gessi, et al.
Published: (2021-09-01)

A3 Adenosine Receptors Modulate Hypoxia-inducible Factor-1a Expression in Human A375 Melanoma Cells
by: Stefania Merighi, et al.
Published: (2005-10-01)

The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric Modulation
by: Fabrizio Vincenzi, et al.
Published: (2020-05-01)

A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin
by: Stefania Merighi, et al.
Published: (2009-10-01)

The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.
by: Fabrizio Vincenzi, et al.
Published: (2012-01-01)

Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455
by: Stefania Gessi, et al.
Published: (2017-12-01)

The function of A2A adenosine receptor and astrocyte in Huntington's disease
by: Szu-Yi Chou, et al.
Published: (2006)

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington’s disease
by: Marta Valenza, et al.
Published: (2007-10-01)

Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields
by: Katia Varani, et al.
Published: (2017-01-01)

A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
by: Fabrizio Vincenzi, et al.
Published: (2013-01-01)

Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
by: Hilary Moffitt, et al.
Published: (2009-11-01)

Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.
by: Fabrizio Vincenzi, et al.
Published: (2013-01-01)

Functional roles of adenosine monophosphate-activated protein kinase ?? (AMPK-??) in Huntington’s disease
by: Tz-Chuen Ju, et al.
Published: (2011)

Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice
by: Antonella Ferrante, et al.
Published: (2021-02-01)

Brain-derived neurotrophic factor in patients with Huntington's disease.
by: Chiara Zuccato, et al.
Published: (2011-01-01)

Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's disease.
by: Caroline L Benn, et al.
Published: (2009-06-01)

Caldag-Gefi Down-Regulation in the Striatum as a Neuroprotective Change in Huntington's Disease.
by: Dunn, Denise E., et al.
Published: (2011)

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
by: Paolo Guidetti, et al.
Published: (2006-07-01)

SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease.
by: Michal Mielcarek, et al.
Published: (2011-01-01)

Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow
by: M. Gianfriddo, et al.
Published: (2004-10-01)

Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models
by: Wei Li, et al.
Published: (2015-07-01)

Altered mTOR signaling in Huntington's Disease
by: Lee, John Hung
Published: (2015)

Insights into GABAAergic system alteration in Huntington's disease
by: Yi-Ting Hsu, et al.
Published: (2018-12-01)

Altered Fractional Anisotropy in Early Huntington's Disease
by: Silky Singh, et al.
Published: (2013-02-01)

A2A adenosine receptors are involved in the reparative response of tendon cells to pulsed electromagnetic fields.
by: Alessandra Colombini, et al.
Published: (2020-01-01)

Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes
by: Natalia Battista, et al.
Published: (2007-07-01)

A2A adenosine receptors are involved in the reparative response of tendon cells to pulsed electromagnetic fields
by: Alessandra Colombini, et al.
Published: (2020-01-01)

Striatal circuit development and its alterations in Huntington's disease
by: Margaux Lebouc, et al.
Published: (2020-11-01)

Altered hypothalamic protein expression in a rat model of Huntington's disease.
by: Wei-na Cong, et al.
Published: (2012-01-01)

Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice
by: M.R. Domenici, et al.
Published: (2007-11-01)

Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
by: J.-C. Liévens, et al.
Published: (2001-10-01)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
by: Daniela Catarzi, et al.
Published: (2019-10-01)

Characterization of spontaneous, transient adenosine release in the caudate-putamen and prefrontal cortex.
by: Michael D Nguyen, et al.
Published: (2014-01-01)

Early changes in transient adenosine during cerebral ischemia and reperfusion injury.
by: Mallikarjunarao Ganesana, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_10rmqm9i5l6t708tk52hrl0k62